Indiana University Simon Cancer Center — Indianapolis, Indiana

Indiana University Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Indiana University Simon Cancer Center has participated in 85 clinical trials with 9 currently active.

Therapeutic areas: Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, Multiple Myeloma.

Sponsors: Archemix Corp., Rebecca Silbermann, Noah Hahn, M.D..

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Simon Cancer Center?

Indiana University Simon Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Simon Cancer Center conducted?

Indiana University Simon Cancer Center has 85 clinical trials on record, with 9 currently active. Their work covers Thrombotic Microangiopathy, Thrombotic Thrombocytopenic Purpura, Multiple Myeloma.

Is Indiana University Simon Cancer Center accredited by Crixeo Health?

Yes — Indiana University Simon Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indiana University Simon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.